Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Torres

Showing results (211-220 of 263) with videos related to

Pageof 27
Sort By:
Gut Microbes|June 22, 2023
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysisAna María Gómez-Pérez, Patricia Ruiz-Limón, Jordi Salas-Salvadó, et al.
Cancers|April 23, 2022
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational StudyAntonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, et al.
American Journal of Human Genetics|August 9, 2016
The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA PhenotypeSeyyedmohsen Hosseinibarkooie, Miriam Peters, Laura Torres-Benito, et al.
Gut Microbes|August 23, 2023
Carbohydrate quality, fecal microbiota and cardiometabolic health in older adults: a cohort studyAlessandro Atzeni, Stephanie K Nishi, Nancy Babio, et al.
The Lancet. Oncology|February 29, 2024
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 studyNaval G Daver, Pau Montesinos, Daniel J DeAngelo, et al.
Antioxidants (Basel, Switzerland)|June 24, 2022
Effect of Low-Dose Radiotherapy on the Circulating Levels of Paraoxonase-1-Related Variables and Markers of Inflammation in Patients with COVID-19 PneumoniaElisabet Rodríguez-Tomàs, Johana C Acosta, Laura Torres-Royo, et al.
The American Journal of Clinical Nutrition|May 21, 2021
Effect on gut microbiota of a 1-y lifestyle intervention with Mediterranean diet compared with energy-reduced Mediterranean diet and physical activity promotion: PREDIMED-Plus StudyJananee Muralidharan, Isabel Moreno-Indias, Mónica Bulló, et al.
Annals of Hematology|April 29, 2021
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patientsMaría P Martínez Sánchez, Juan Eduardo Megías-Vericat, Rebeca Rodríguez-Veiga, et al.
International Journal of Molecular Sciences|April 27, 2024
Phenotypic Expression and Outcomes in Patients with the p.Arg301Gln <i>GLA</i> Variant in Anderson-Fabry DiseaseRocío Blanco, Yolanda Rico-Ramírez, Álvaro Hermida-Ameijeiras, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 4, 2023
Increase from low to moderate, but not high, caffeinated coffee consumption is associated with favorable changes in body fatMatthias Henn, Nancy Babio, Dora Romaguera, et al.
Pageof 27

Showing results (211-220 of 263) with videos related to

Sort By:
Pageof 27
Gut Microbes|June 22, 2023
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysisAna María Gómez-Pérez, Patricia Ruiz-Limón, Jordi Salas-Salvadó, et al.
Cancers|April 23, 2022
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational StudyAntonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, et al.
American Journal of Human Genetics|August 9, 2016
The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA PhenotypeSeyyedmohsen Hosseinibarkooie, Miriam Peters, Laura Torres-Benito, et al.
Gut Microbes|August 23, 2023
Carbohydrate quality, fecal microbiota and cardiometabolic health in older adults: a cohort studyAlessandro Atzeni, Stephanie K Nishi, Nancy Babio, et al.
The Lancet. Oncology|February 29, 2024
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 studyNaval G Daver, Pau Montesinos, Daniel J DeAngelo, et al.
Antioxidants (Basel, Switzerland)|June 24, 2022
Effect of Low-Dose Radiotherapy on the Circulating Levels of Paraoxonase-1-Related Variables and Markers of Inflammation in Patients with COVID-19 PneumoniaElisabet Rodríguez-Tomàs, Johana C Acosta, Laura Torres-Royo, et al.
The American Journal of Clinical Nutrition|May 21, 2021
Effect on gut microbiota of a 1-y lifestyle intervention with Mediterranean diet compared with energy-reduced Mediterranean diet and physical activity promotion: PREDIMED-Plus StudyJananee Muralidharan, Isabel Moreno-Indias, Mónica Bulló, et al.
Annals of Hematology|April 29, 2021
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patientsMaría P Martínez Sánchez, Juan Eduardo Megías-Vericat, Rebeca Rodríguez-Veiga, et al.
International Journal of Molecular Sciences|April 27, 2024
Phenotypic Expression and Outcomes in Patients with the p.Arg301Gln <i>GLA</i> Variant in Anderson-Fabry DiseaseRocío Blanco, Yolanda Rico-Ramírez, Álvaro Hermida-Ameijeiras, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 4, 2023
Increase from low to moderate, but not high, caffeinated coffee consumption is associated with favorable changes in body fatMatthias Henn, Nancy Babio, Dora Romaguera, et al.
Pageof 27